Dr Lal Pathlabs' Q1 FY 2025-26 Quarter Results
- 31 Jul 2025
Result Summary
- Dr Lal Pathlabs Ltd reported a 23.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 12.1%.
- Its expenses for the quarter were up by 16.4% QoQ and 9.4% YoY.
- The net profit increased 56.2% QoQ and increased 24.3% YoY.
- The earnings per share (EPS) of Dr Lal Pathlabs Ltd stood at 15.8 during Q1 FY 2025-26.
Financial Statments for Q1 FY 2025-26
| (₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 697.90 | 563.80 | 622.50 | 23.8% | 12.1% |
Total Expenses | 516.80 | 443.90 | 472.60 | 16.4% | 9.4% |
Profit Before Tax | 181.10 | 119.90 | 149.90 | 51.0% | 20.8% |
Tax | 47.10 | 34.10 | 42.10 | 38.1% | 11.9% |
Profit After Tax | 134.00 | 85.80 | 107.80 | 56.2% | 24.3% |
Earnings Per Share | 15.80 | 10.10 | 12.80 | 56.4% | 23.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Dr. Lal Pathlabs Ltd is a prominent diagnostic and related healthcare services company based in India. The company primarily operates in the healthcare industry, offering a comprehensive range of diagnostic and pathology tests. As a leading player in the diagnostic services sector, Dr. Lal Pathlabs provides services such as blood testing, radiology imaging, and other specialized pathological services. The company has established a significant presence across India with a network of laboratories and patient service centers. Recent major developments for the company are not available in the provided data.
Revenue
For the first quarter of the fiscal year 2026 (Q1FY26), Dr. Lal Pathlabs Ltd reported a total income of ₹697.90 crores. This marks a quarter-over-quarter (QoQ) increase of 23.8% from ₹563.80 crores in the fourth quarter of the fiscal year 2025 (Q4FY25). Year-over-year (YoY), total income rose by 12.1% from ₹622.50 crores in the first quarter of the fiscal year 2025 (Q1FY25). This growth in total income reflects a significant upward trend in revenue generation over both the short and long term.
Profitability
The company reported a profit before tax (PBT) of ₹181.10 crores in Q1FY26, which represents a QoQ increase of 51.0% compared to ₹119.90 crores in Q4FY25 and a YoY increase of 20.8% from ₹149.90 crores in Q1FY25. The tax expense for Q1FY26 was ₹47.10 crores, showing a QoQ increase of 38.1% from ₹34.10 crores in Q4FY25 and an 11.9% YoY increase from ₹42.10 crores in Q1FY25. Consequently, the profit after tax (PAT) for Q1FY26 reached ₹134.00 crores, reflecting a 56.2% QoQ increase from ₹85.80 crores in Q4FY25 and a 24.3% YoY increase from ₹107.80 crores in Q1FY25.
Operating Metrics
Dr. Lal Pathlabs Ltd's operating expenses for Q1FY26 totaled ₹516.80 crores, which is a 16.4% increase QoQ from ₹443.90 crores in Q4FY25 and a 9.4% increase YoY from ₹472.60 crores in Q1FY25. The earnings per share (EPS) for Q1FY26 was ₹15.80, marking a 56.4% increase QoQ from ₹10.10 in Q4FY25 and a 23.4% increase YoY from ₹12.80 in Q1FY25. These metrics indicate substantial growth in the company's earnings performance and cost efficiency over the analyzed periods.
FAQs
When was Dr Lal Pathlabs Ltd Q1 FY 2025-26 result announced?
Dr Lal Pathlabs Ltd announced its Q1 FY 2025-26 results on 31 July, 2025.
What are Dr Lal Pathlabs Ltd quarterly results?
Dr Lal Pathlabs Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
What were the key highlights of Dr Lal Pathlabs Ltd Q1 FY 2025-26 results?
Key highlights of Dr Lal Pathlabs Ltd Q1 FY 2025-26 results include:
- Revenue: ₹697.90 crore
- Net Profit: ₹134.00 crore
- EBITDA: ₹220.40 crore
- Year-over-Year Growth: 12.1%
- Quarter-over-Quarter Growth: 23.8%
How did Dr Lal Pathlabs Ltd net profit perform in this quarter?
Dr Lal Pathlabs Ltd reported a net profit of ₹134.00 crore in Q1 FY 2025-26, reflecting a 24.3% year-over-year growth.
What was Dr Lal Pathlabs Ltd revenue in Q1 FY 2025-26?
Dr Lal Pathlabs Ltd posted a revenue of ₹697.90 crore in Q1 FY 2025-26.